Chapters

Transcript

Video

How does the complexity and heterogeneity of NCFBE—with underlying inflammatory and infectious precipitants—affect selection of specific therapeutic agents that might be used as part of multi-modal therapy?


Created by

CMEducation Resources iQ&A Bronchiectasis (NCFBE) Pulmonary Medicine Intelligence Zone

Presenter

Professor David E. Griffith, MD

Professor David E. Griffith, MD

Professor of Medicine
National Jewish Health
Denver, Colorado, USA